These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4706747)

  • 1. Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs.
    Stoelting RK; Martz RC; Gartner J; Creasser C; Brown DJ; Forney RB
    Anesthesiology; 1973 Jun; 38(6):521-4. PubMed ID: 4706747
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of delta-9-tetrahydrocannabinol on cyclopropane MAC in the rat.
    Vitez TS; Way WL; Miller RD; Eger EI
    Anesthesiology; 1973 Jun; 38(6):525-7. PubMed ID: 4706748
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cocaine administration on halothane MAC in dogs.
    Stoelting RK; Creasser CW; Martz RC
    Anesth Analg; 1975; 54(4):422-4. PubMed ID: 1170777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of the minimum alveolar concentration (MAC) of halothane in the white New Zealand rabbit.
    Davis NL; Nunnally RL; Malinin TI
    Br J Anaesth; 1975 Mar; 47(3):341-5. PubMed ID: 1138742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane MAC in dogs unchanged by phenobarbital.
    Viegas O; Stoelting RK
    Anesth Analg; 1976; 55(5):677-9. PubMed ID: 987722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of repeated doses of l-delta 8-trans-tetrahydrocannabinol on schedule-controlled temporally-spaced responding of rats.
    Frankenheim JM
    Psychopharmacologia; 1974; 38(2):125-44. PubMed ID: 4460069
    [No Abstract]   [Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol, EEG and behavior:the importance of adaptation to the testing milieu.
    Constoe PF; Jones BC; Chin L
    Pharmacol Biochem Behav; 1975; 3(2):173-7. PubMed ID: 1144477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attack behaviour in mice inhibited by -9-tetrahydrocannabinol.
    Kilbey MM; Fritchie GE; McLendon DM; Johnson KM
    Nature; 1972 Aug; 238(5365):463-5. PubMed ID: 4561858
    [No Abstract]   [Full Text] [Related]  

  • 11. Delta-9-tetrahydrocannabinol and glucose tolerance.
    Hollister LE; Reaven GM
    Clin Pharmacol Ther; 1974 Aug; 16(2):297-302. PubMed ID: 4851289
    [No Abstract]   [Full Text] [Related]  

  • 12. Verapamil decreases MAC for halothane in dogs.
    Maze M; Mason DM; Kates RE
    Anesthesiology; 1983 Oct; 59(4):327-9. PubMed ID: 6614542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of teratological effects of intravenous, subcutaneous, and intragastric administration of delta9-tetrahydrocannabinol in mice.
    Joneja MG
    Toxicol Appl Pharmacol; 1976 Apr; 36(1):151-62. PubMed ID: 1273835
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 15. Gas chromatography. Halothane in blood and tissues.
    Cervenko FW
    Proc R Soc Med; 1968 May; 61(5):528-30. PubMed ID: 5655251
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys.
    Harris RT; Waters W; McLendon D
    Psychopharmacologia; 1974 Jun; 37(1):23-9. PubMed ID: 4413316
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 18. Depth perception in rats following acute or chronic injections of D1- 9 tetrahydrocannabinol.
    Fried PA; Husband CA
    Life Sci I; 1973 Apr; 12(7):289-95. PubMed ID: 4695123
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute and chronic effects of delta9-tetrahydrocannabinol on food intake by rats.
    Sofia RD; Barry H
    Psychopharmacologia; 1974; 39(3):213-22. PubMed ID: 4427988
    [No Abstract]   [Full Text] [Related]  

  • 20. 9 -Tetrahydrocannabinol: effects of EEG and behavior of rhesus monkeys.
    Martinez JL; Stadnicki SW; Schaeppi UH
    Life Sci I; 1972 Jul; 11(13):643-51. PubMed ID: 4632405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.